SWOG clinical trial number
SWOG-8310
Evaluation of Aziridinylbenzoquinone (AZQ) (NSC-182986) in Refractory and Relapsing Myeloma
Closed
Phase
Published
Abbreviated Title
Evaluation of Aziridinylbenzoquinone (AZQ) (NSC-182986) in Refractory and Relapsing Myeloma
Activated
12/07/1984
Closed
11/01/1986
Publication Information Expand/Collapse
1987
Phase II trial of diaziquone in patients with refractory andrelapsing multiple myeloma: A Southwest Oncology Group Study.